BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260209T150000
DTEND;TZID=Europe/Stockholm:20260209T160000
DTSTAMP:20260602T175040
CREATED:20260123T120235Z
LAST-MODIFIED:20260126T114030Z
UID:193774-1770649200-1770652800@www.scilifelab.se
SUMMARY:PULSE Challenge: From Serendipity to Design Principles Molecular Glues as a Prelude to RIPTACs
DESCRIPTION:Traditionally viewed as inhibitors\, small molecules have evolved through the discovery of molecular glues—compounds that create function by stabilizing protein-protein interactions. This shift from serendipitous discovery to “induced proximity” has expanded the druggable proteome and redefined how we control cellular behavior. \n\n\n\nThis talk traces the evolution of molecular glues\, framing them as versatile proximity-inducing agents rather than just degradation tools. I emphasize their impact on our understanding of protein surfaces and cellular organization. The second half introduces Regulated Induced Proximity Targeting Chimeras (RIPTACs). I highlight HLD-0915\, a novel RIPTAC targeting prostate cancer. In preclinical models\, HLD-0915 demonstrated tumor regression and a favorable therapeutic index\, even in drug-resistant cases. Finally\, I present Phase 1 data from mCRPC patients\, showing strong tolerability and encouraging anti-tumor activity in heavily pretreated populations. \n\n\n\nHost: Vasanthanathan PoongavanamModerator: Per Arvidsson \n\n\n\nThe seminar series PULSE Challenge is connected to the MSCA co-funded* postdoctoral program SciLifeLab PULSE\, that will train 48 future leaders in life sciences. The program focuses on innovative\, fundamental and translational research carried out in supportive and diverse academic and industrial environments\, preparing postdocs with necessary skills for long-term career sustainability. Click HERE to find out more about SciLifeLab PULSE \n\n\n\n\n\n\n\nOn-line event via Zoom \n\n\n\nRegister Here\n\n\n\n\n\n\n\n\n\n\n\n\n\nPresenter: Dr. Muthukumaran Venkatachalapathy  \n\n\n\nBiography:Dr. Muthukumaran Venkatachalapathy is currently an Associate Research Scientist in the Department of Chemistry at Yale University (with Professor Craig Crews and Prof David Spiegel). With a strong background in Chemical Biology\, he earned his Ph.D. from the Max Planck Institute in Dortmund\, Germany. His research interests focus on developing novel chemical biology modalities for targeted protein degradation and therapeutic discovery
URL:https://www.scilifelab.se/event/pulse-challenge-from-serendipity-to-design-principles-molecular-glues-as-a-prelude-to-riptacs/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2025/02/Bild1-e1770905208628.png
END:VEVENT
END:VCALENDAR